TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

about

Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells

P2860

Q58773797-FFED1796-71DC-4F63-8A89-8681FE16CAE0

P2860

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

Item

http://www.wikidata.org/entity/Q47134730

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@en

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@nl

type

Item

label

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@en

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@nl

prefLabel

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@en

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@nl

P1476

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

@en

P2093

An-Jing Chen

http://www.w3.org/2001/XMLSchema#string

Bin Huang

http://www.w3.org/2001/XMLSchema#string

Gang Li

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Ming-Zhi Han

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Ran Xu

http://www.w3.org/2001/XMLSchema#string

Shi-Lei Ni

http://www.w3.org/2001/XMLSchema#string

Shuai Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Jie Li

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

IDH1 and IDH2 mutations in gliomas

Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

Global cancer statistics, 2012

FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways

Transforming growth factor β as regulator of cancer stemness and metastasis

Malignant gliomas in adults

TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse.

Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis.

P2888

s13046-017-0619-9

P304

155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-017-0619-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092562959

http://www.w3.org/2001/XMLSchema#string

P698

29110682

http://www.w3.org/2001/XMLSchema#string

P932

5674233

http://www.w3.org/2001/XMLSchema#string

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

about

P2860

P2860

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932